Lucile Baseggio Selected Research

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)

12/2019

How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lucile Baseggio Research Topics

Disease

14	Lymphoma (Lymphomas) 03/2024 - 01/2002
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2019 - 04/2011
3	Neoplasms (Cancer) 01/2016 - 04/2005
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2007 - 01/2002
2	Cytopenia 10/2023 - 08/2014
2	B-Cell Lymphoma (Lymphoma, B Cell) 05/2018 - 01/2017
2	Lymphocytosis 01/2017 - 08/2014
1	Residual Neoplasm 03/2024
1	B-Cell Prolymphocytic Leukemia 01/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2019
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2019
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 03/2019
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 05/2018
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018
1	Pneumonia (Pneumonitis) 01/2016
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2016
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2016
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2011
1	Carcinogenesis 12/2009
1	T-Cell Lymphoma (Lymphoma, T Cell) 12/2006
1	Disease Progression 05/2004
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2004

Drug/Important Bio-Agent (IBA)

3	Rituximab (Mabthera)FDA Link 03/2024 - 01/2018
3	ibrutinibIBA 12/2019 - 01/2016
2	Bendamustine Hydrochloride FDA Link 03/2024 - 12/2018
2	Immunoglobulins (Immunoglobulin)IBA 10/2023 - 04/2005
2	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2018 - 01/2016
2	AntigensIBA 01/2016 - 04/2005
2	thiamine triphosphorate (TTP)IBA 03/2014 - 01/2002
2	Proteins (Proteins, Gene)FDA Link 04/2011 - 01/2002
2	Interleukin-10 (Interleukin 10)IBA 11/2007 - 05/2004
1	AntibodiesIBA 10/2023
1	Brentuximab VedotinIBA 01/2021
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Asparaginase (Elspar)FDA Link 12/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2019
1	Methotrexate (Mexate)FDA LinkGeneric 12/2019
1	Prednisone (Sone)FDA LinkGeneric 12/2019
1	Vincristine (Oncovin)FDA LinkGeneric 12/2019
1	Formaldehyde (Formol)FDA Link 01/2018
1	ParaffinIBA 01/2018
1	Co-Repressor ProteinsIBA 10/2017
1	Cyclin D3IBA 01/2017
1	GlycolipidsIBA 01/2016
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2016
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2016
1	Histones (Histone)IBA 04/2011
1	Signal Recognition ParticleIBA 04/2011
1	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2009
1	CD3 ComplexIBA 12/2006
1	CytokinesIBA 05/2004
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2002
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2002
1	Messenger RNA (mRNA)IBA 01/2002
1	LipopolysaccharidesIBA 01/2002

Therapy/Procedure

3	Therapeutics 01/2023 - 01/2016
2	Splenectomy 12/2018 - 08/2014
1	Drug Therapy (Chemotherapy) 12/2019
1	Breast Implants (Breast Implant) 03/2019
1	Immunotherapy 12/2018
1	Induction Chemotherapy 01/2018
1	Injections 01/2016
1	Lasers (Laser) 04/2011